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UNIT 9.4Selection for Catalytic Function with Nucleic
Acids
Existing protocols for in vitro selection of catalytic polynucleotides are largely derived
from the judicious assembly of experimental techniques routinely used in molecular
biology. Each new protocol requires the use of the specific techniques that will facilitate
the isolation of ribozymes or deoxyribozymes with the desired catalytic activity—that is,
the protocol must be designed so as to harness this catalytic activity to help propel the
selection process itself. This unit outlines several representative protocols for those who
wish to repeat successful selection experiments and for those who seek a conceptual basis
to aid in the design and implementation of new selective-amplification protocols for
nucleic acids.
STRATEGIC PLANNING
Amplifying RNA and DNA Molecules
Several methods for amplifying RNA and DNA molecules are commonly used in
molecular biology and, with little or no modification, can be made to play a central role
in the selective amplification of catalytic nucleic acids. RNA molecules can be synthe-
sized by chemical means (Wincott et al., 1995) or prepared in large quantities by
enzymatic synthesis from DNA templates using T7 RNA polymerase (Milligan and
Uhlenbeck, 1989). The conversion of RNA to DNA can be achieved using reverse
transcriptase, which is a component of RT-PCR protocols for RNA amplification
(Rashtchian, 1994). The details of these methods are described elsewhere (see UNITS 9.2 &
9.3) and therefore are not covered in this unit.
Creating Variants of Existing Ribozymes
Basic Protocols 1, 2, and 4 detail the in vitro selection of existing ribozymes. Basic
Protocols 1 and 2 describe the selection of group I and RNase P RNA-cleaving ribozyme
variants, respectively. Basic Protocol 4 describes the propagation of RNA ligase ribozyme
variants by continuous evolution. The natural “self-cleaving” ribozymes are quite small
(Symons, 1992), and as a result libraries of variant ribozymes can be prepared by in vitro
transcription from synthetic DNA templates that carry partially or fully randomized
sequence domains (see UNIT 9.3). However, given the sizes of group I, group II, and RNase
P ribozymes, to introduce mutants into larger catalysts it is necessary to use alternative
methods. Fortunately, a number of excellent protocols exist for constructing starting pools
of large ribozymes that allow the incorporation of the most desirable mutational patterns.
The protocol most commonly used involves performing the polymerase chain reaction
(PCR) under mutagenic conditions (Cadwell and Joyce, 1992; Vartanian et al., 1996).
These and related DNA amplification protocols are typically used to introduce mutations
over the entire length of larger ribozymes. Alternatively, mutations can be introduced in
a more focused manner through the targeted integration of mutagenized oligonucleotides
into ribozyme-encoding templates (Joyce and Inoue, 1989). Different combinations of
fixed, mutagenized, and random-sequence domains can be joined using conventional
DNA ligation methods. Alternatively, the DNA shuffling methods (Stemmer, 1994; Zhao
et al., 1998) developed for the directed evolution of proteins should also be useful for the
preparation of RNA populations by recombination of related ribozymes.
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Creating New Ribozymes from Random-Sequence Pools
One of the more exciting applications of in vitro selection is the isolation of new classes
of catalytic RNAs and DNAs. Usually, new catalysts are isolated from random-sequence
pools, or from pools that are biased in favor of a preexisting functional domain. Basic
Protocol 3 details the methods used to isolate ribozymes with polynucleotide kinase
activity. In its original manifestation (Lorsch and Szostak, 1994), this selection began
with an RNA pool that, in addition to random-sequence domains, carried a mutagenized
domain that binds ATP. This creates a biased pool wherein greater numbers of molecules
are expected to bind the substrate for the reaction. This strategy could be used for other
selection efforts, although a starting pool made exclusively of random-sequence mole-
cules may be adequate for many selection goals.
BASIC
PROTOCOL 1
IN VITRO SELECTION OF GROUP I RIBOZYME VARIANTS
A prolific method for the directed evolution of the group I ribozyme was outlined by Joyce
and Inouye (1989) and has been used both to probe the structure and function of group I
ribozymes and to demonstrate various features of the in vitro selection process. This
method exploits the fact that certain constructs of the group I ribozyme catalyze the
reversal of the second step of RNA splicing, thereby generating a 3′-tagged ribozyme
(Fig. 9.4.1). These self-modifying RNAs are selectively amplified using self-sustained
sequence replication (3SR; Guatelli et al., 1990; Fahy et al., 1991) and the resulting RNAs
are used to initiate the next round of selection. Although the wild-type ribozyme cleaves
DNA substrates poorly (Robertson and Joyce, 1990; Herschlag and Cech, 1990), the
isolation of ribozyme variants with improved DNA cleavage activity was one of the
earliest achievements for catalytic RNA selections. The details of this in vitro selection
protocol are given below.
The following protocol has been adapted from that reported by Beaudry and Joyce (1992).
For different desired outcomes, the ribozyme pool may be uniquely mutagenized and
subjected to a variation of the protocol described here. It is important to note that the
nucleotide sequence of the substrate RNA or DNA used with the ribozyme reaction must
be made complementary to the internal guide sequence (IGS) of the ribozyme (Cech,
1990).
NOTE: Buffer solutions, reagents, and oligonucleotides used in all protocols described
in this unit should be stored frozen at −20°C and thawed only when needed. Protein
enzymes should be stored according to the vendor’s instructions.
Materials
2× selection buffer: 60 mM EPPS [4-(2-hydroxethyl)-1-piperazinepropanesulfonic
acid; pH 7.5 at 23°C)/20 mM MgCl2
Substrate oligonucleotide solution (200 pmol/µL)
100% ethanol, −20°C
TE buffer, pH 7.5 at 23°C (APPENDIX 2A)
10× 3SR buffer: 500 mM Tris⋅Cl (APPENDIX 2A; pH 7.5 at 23°C)/100 mM MgCl2/50
mM dithiothreitol (DTT)
10× 3SR NTP/dNTP mix: 20 mM each of the four ribonucleoside-5′-triphosphates
and 2 mM each of the four deoxyribonucleoside-5′-triphosphates (see APPENDIX
2A for details of NTP and dNTP preparation and storage)
DNA primer 1: complementary to the 3′ tail of the modified ribozymes (20
pmol/µL)
DNA primer 2: homologous to the 5′ end of each ribozyme (20 pmol/µL)
50 U/µL T7 RNAP (New England Biolabs)
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10 U/µL avian myoblastosis virus reverse transcriptase (AMV RT; Amersham)
0.3 N NaOH
3 M sodium acetate, pH 5.2 (APPENDIX 2A)
10× PCR buffer: 100 mM Tris⋅Cl (pH 8.3 at 23°C)/15 mM MgCl2/500 mM
KCl/0.1% (w/v) gelatin
10× PCR dNTP mix: 2 mM each of the four deoxyribonucleoside-5′-triphosphates
(see APPENDIX 2A for details of dNTP preparation and storage)
DNA primer 3: complementary to the original 3′ terminus of the unmodified
ribozymes (20 pmol/µL)
5 U/µL Taq DNA polymerase (Boehringer Mannheim) diluted 20:1 in distilled
H2O to 0.25 U/µL final concentration
Additional reagents and equipment for agarose gel electrophoresis (e.g., CPMB UNIT
2.5A) and DNA sequencing (APPENDIX 3B)
Perform the ribozyme reaction
1. Prepare mutagenized RNA pool for group I ribozyme selection, at 10 pmol/µL.
Figure 9.4.1 An in vitro selection scheme for the directed evolution of group I ribozymes. A pool
of group I ribozyme variants (each carrying a 3′-terminal guanidyl residue) are incubated with a
substrate oligonucleotide. Those ribozymes that catalyze the cleavage of the substrate via a
phosphoester transfer reaction acquire a fragment of the substrate at their 3′ terminus. This
oligonucleotide tail acts as a primer-binding site that tags the functional ribozyme variants for
amplification by self-sustained sequence replication (3SR) using two primer DNAs (1 and 2). PCR
is subsequently performed using a different set of DNA primers (2 and 3) that regenerate the desired
3′ terminus upon transcription of the resulting double-stranded DNA (dsDNA) template. Although
the 3SR process is a significant source of mutations, additional sequence variation can be created
through the use of mutagenic PCR (Support Protocol 1). T7 RNAP and RT represent T7 RNA
polymerase and reverse transcriptase, respectively. Inset: sequence of substrate, including the tag
sequence that is transferred to the 3′ terminus of the ribozyme upon cleavage.
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Due to its large size, starting pools for group I ribozyme selection cannot be prepared easily
by chemical synthesis. However, there are several methods, such as mutagenic PCR or
site-directed mutagenesis, that can be used for this purpose (see discussion above).
Beaudry and Joyce (1992) made use of four mutagenic oligonucleotides that were used to
form a pool of DNA templates that encode group I ribozyme variants. The mutations
brought about by these oligonucleotides are located within the catalytic core of the
ribozyme and were introduced at these locations to screen more efficiently for variant
ribozymes with altered catalytic function. This protocol for the introduction of a specific
level of sequence degeneracy over defined regions in DNA templates is described in detail
elsewhere (Joyce and Inoue, 1989; Beaudry and Joyce, 1992). The resulting pool of DNA
templates is transcribed in vitro using T7 RNAP (UNIT 9.3; Milligan and Uhlenbeck, 1989),
and purified by polyacrylamide gel electrophoresis (APPENDIX 3B; Sambrook et al., 1989).
Alternatively, mutagenic PCR (Support Protocol 1, Cadwell and Joyce, 1992) or hypermu-
tagenic PCR (Vartanian et al., 1996) methods can be used to introduce mutations through-
out the entire molecule.
2. Combine 100 µL of 2× selection buffer, 70 µL distilled water, and 20 µL of 10
pmol/µL ribozyme solution. Allow mixture to equilibrate several minutes at 37°C.
3. Initiate the ribozyme reaction by the addition of 10 µL of 200 pmol/µL substrate
oligonucleotide. Incubate 1 hr at 37°C.
4. Precipitate the RNA by the addition of 500 µL of 100% ethanol, −20°C. Pellet the
precipitate by centrifugation for 15 min at 15,000 × g, 4°C. Resuspend the pelleted
RNA in 20 µL TE buffer.
During the first few rounds of selection it may be best to incubate the ribozyme reaction
for extended times to allow suboptimal ribozymes greater opportunity to react. Because of
the inherent mutagenic nature of the polymerase enzymes used for RNA and DNA amplifi-
cation, or through the use of mutagenic PCR, the suboptimal ribozymes may acquire
mutations that improve catalytic performance. In later rounds, reducing the reaction time
will favor those ribozymes with faster catalytic rates. The time required to complete each
round may vary as a result of alterations in the incubation times or of the intermittent use
of accessory methods such as mutagenic PCR or additional purification steps. In practice,
the completion of a single round of selection that includes the following amplification
components requires 2 to 3 days.
Selectively amplify by 3SR
5. Combine 20 µL resuspended pool RNA with the following reagents:
35 µL distilled H2O
10 µL 10× 3SR buffer
10 µL 10× 3SR NTP/dNTP mix
5 µL 20 pmol/µL DNA primer 1
5 µL 20 pmol/µL DNA primer 2
10 µL 50 U/µL T7 RNAP
5 µL 10 U/µL AMV RT.
Incubate mixture 1 hr at 37°C.
6. Terminate reaction by the addition of 10 µL of 3 M sodium acetate, pH 5.2, and then
precipitate the RNA/DNA mixture by the addition of 275 µL of 100% ethanol, −20°C.
Pellet the resulting nucleic acid precipitate by centrifugation as described in step 4.
7. To destroy the remaining RNA, resuspend the resulting pellet in 200 µL of 0.3 N
NaOH and heat to 90°C for 10 min.
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8. Precipitate the DNA by adding 20 µL of 3 M sodium acetate, pH 5.2, and 550 µL of
100% ethanol, −20°C, then pellet by centrifugation as described in step 4. Resuspend
the pelleted DNA in 20 µL TE buffer.
Perform nested PCR amplification of cDNA
9. Combine 20 µL cDNA with the following reagents:
48 µL distilled H2O
10 µL 10× PCR buffer
10 µL 10× PCR dNTP mix
1 µL DNA primer 2
1 µL DNA primer 3
10 µL 0.25 U/µL Taq DNA polymerase.
In order to restore the original untagged terminus of the RNA pool, cDNA products of the
3SR reaction are amplified by PCR using a new DNA primer combination (primers 2 and
3). Primer 3 is complementary to the 3′-terminal bases of the ribozyme immediately
preceding the tag sequence that was acquired during the preceding ribozyme reaction. This
nested PCR reaction deletes the tag sequence and restores the guanosine residue required
by the ribozyme for catalytic activity in the next selection cycle.
10. Perform up to 30 thermal cycles, each consisting of repetitive denaturing, annealing,
and extension incubations (e.g., 30 sec at 92°C, 30 sec at 45°C, 30 sec at 72°C).
Optimal temperatures and incubation times must be established for different template and
primer combinations.
11. Analyze the PCR products by agarose gel electrophoresis (e.g., Sambrook et al., 1989,
or CPMB UNIT 2.5A) to confirm the presence of template DNA.
12. The resulting double-stranded DNA is now ready to be transcribed (Milligan and
Uhlenbeck, 1989; see also UNIT 9.3) to create the RNA pool for the next round of
selection, thereby completing the selective-amplification cycle. Alternatively, the
DNA can be cloned and sequenced (APPENDIX 3B) in order to examine individual RNAs
that populate the selected pool.
SUPPORT
PROTOCOL 1
MUTAGENIC PCR
Nucleic acid amplification processes such as RNA polymerization, reverse transcription,
and the polymerase chain reaction unavoidably mutagenic, and therefore facilitate the
accumulation of genetic diversity as in vitro selection progresses. However, in most cases
it is beneficial to increase the frequency of mutations that are being introduced into the
population in order to more rapidly and thoroughly explore sequence variations. The
following support protocol provides a substantial increase in the error rate of DNA
synthesis during the polymerase chain reaction. This protocol provides a mutation rate of
approximately 0.7% per position with no strong bias for base substitutions. However,
variation of the reaction conditions, particularly the concentrations of manganese and the
relative concentrations of the dNTPs can significantly affect the mutagenic character of
the reaction. The following protocol for mutagenic PCR is adapted from Cadwell and
Joyce, 1992.
Materials
DNA Primer 2: homologous to the 5′ end of each ribozyme (20 pmol/µL)
DNA Primer 3: complementary to the original 3′ terminus of the unmodified
ribozymes (20 pmol/µL)
DNA template: 5 pmole/µL
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10× mutagenic PCR buffer: 100 mM Tris•Cl (pH 8.3 at 23°C)/70 mM MgCl2/500
mM KCl/0.1% (w/v) gelatin
10× mutagenic PCR dNTP mix: 2 mM each of dGTP and dATP/10 mM each of
dCTP and dTTP
5 mM MnCl2
5 U/µL Taq DNA polymerase (Boehringer Mannheim) diluted 20:1 in dH2O to
0.25 U/µL final concentration
1. Combine 4 µL DNA template with the following reagents:
54 µL distilled H2O
10 µL 10× mutagenic PCR buffer
10 µL 10× mutagenic PCR dNTP mix
1 µL DNA Primer 2
1 µL DNA Primer 3
10 µL 5 mM MnCl2
10 µL 0.25 U/µL Taq DNA polymerase.
 To prevent precipitation of reagents, the MnCl2 should be added just prior to the addition
of Taq DNA polymerase and initiation of the reaction.
 2. Perform up to 30 thermal cycles as described in step 10 of Basic Protocol 1.
Analyze the products and transcribe RNA as described in steps 11 and 12 of Basic
Protocol 1.
BASIC
PROTOCOL 2
IN VITRO SELECTION OF RNase P RIBOZYME VARIANTS
Several groups have reported the use of RNase P for the in vitro selection of new or
improved substrates (Yuan and Altman, 1994; Liu and Altman, 1994; Pan, 1995) or for
the selection of variant ribozymes themselves (Frank et al., 1996; Frank and Pace, 1997).
In the latter examples, a self-cleaving RNA system consisting of a ribozyme/substrate
construct was generated to facilitate the separation of active from inactive ribozyme
variants. Since RNase P catalyzes the hydrolysis of RNA substrates, in vitro selection
schemes for this ribozyme cannot take advantage of a self-ligation reaction. In contrast,
mutagenized populations of this construct, termed TP292∆, are immobilized on a thio-
philic column via a phosphorothioate nucleotide attached to each RNA molecule (Fig.
9.4.2). Separation of active TP292∆ variants is achieved upon RNA self-cleavage, which
liberates ribozymes from the matrix—a process that has been termed “catalytic elution”
(Breaker, 1997a). As a result of the specific methods used for this selection, specific
changes must be made to the conventional protocols for RNA preparation and manipula-
tion; these alterations are highlighted in the protocol given here. This procedure, adapted
from Frank et al. (1996), can be broadly applied for the study of RNase P structure and
function using in vitro selection.
In vitro transcription must be carried out under specialized conditions in order to include
the 5′-thiophosphate moiety and to minimize the fraction of precursor RNAs that undergo
self cleavage prior to the selection phase of the process. The efficiency of RNA transcrip-
tion by T7 RNAP is substantially improved for templates that encode for the presence of
a 5′-terminal guanosine nucleotide in the RNA transcript. As a result, different chemical
groups can be incorporated into RNA during the transcription process if modified
guanosine nucleotides are included in the reaction. This fact is exploited here to create
pool RNAs that begin with a 5′-phosphorothioate residue. The in vitro transcription
protocol is an adaptation of that described by Milligan and Uhlenbeck (1989) for the
enzymatic synthesis of RNA.
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Materials
10× transcription buffer (see recipe)
10× transcription NTP mix: 10 mM each of the four
ribonucleoside-5′-triphosphates
50% (v/v) aqueous glycerol
Double-stranded template DNA (at 10 pmol/µL)
100 mM guanosine-5′-phosphorothioate (GMPS; Amersham Life
Sciences–NucleixPlus)
10 mCi/mL [α-32P]GTP (3000 Ci/mmol)
50 U/µL T7 RNAP (New England Biolabs)
0.5 M EDTA, pH 8.0 (APPENDIX 2A)
100% ethanol, −20°C
2× urea loading buffer (APPENDIX 2A)
Gel elution buffer (see recipe)
TE buffer, pH 7.5 (APPENDIX 2A)
Sulfolink gel (aqueous slurry of beaded agarose; Pierce)
Loading buffer: 40% methanol/20 mM sodium phosphate (pH 8.9)/0.1% SDS
(APPENDIX 2A)/5 mM EDTA
Nonpool RNAs: e.g., Bacillus subtilis rRNA
Wash buffer: 3 M NaCl/50 mM Tris⋅Cl (pH 8; APPENDIX 2A)/5 mM EDTA
Reaction buffer −Mg2+ (see recipe)
1 M MgCl2
Glycogen
Sterile razor blade
Liquid scintillation counter
Figure 9.4.2 A selective-amplification strategy for the isolation of RNase P ribozyme variants. A
pool of double-stranded DNA templates that encode for TP292∆ variants is transcribed in vitro using
T7 RNA polymerase (T7 RNAP) in the presence of 5′-guanosine monophosphorothioate (GMPS).
The resulting RNA pool is immobilized on a thiophilic beaded-agarose matrix. Competent variants
of the ribozyme-substrate fusion are recovered from the matrix under permissive reaction conditions
(added Mg2+) and amplified by RT-PCR. The cycle is repeated until RNAs with the desired activity
dominate the amplified population. (−) and (+) represent the T7 RNAP promoter sequences that
reside on the nontemplate and template strands, respectively. Shaded box represents the agarose
matrix. Arrowhead identifies the site of ribozyme cleavage.
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Additional reagents and equipment for denaturing polyacrylamide gel
electrophoresis (PAGE; e.g., APPENDIX 3B or CPMB UNIT 7.6) and RT-PCR (UNIT 9.3)
Perform in vitro transcription
1. Combine in a 1.5-mL microcentrifuge tube (100 µl total volume):
30.5 µL distilled H2O
10 µL 10× transcription buffer
10 µL 10× transcription NTP mix
15 µL 50% aqueous glycerol
2 µL 10 pmol/µL template DNA
7.5 µL 100 mM GMPS
5 µL 10 mCi/mL [α-32P]GTP
20 µL 50 U/µL T7 RNAP.
Incubate mixture 12 hr at 12°C.
2. Terminate reaction by the addition of 3 µL of 0.5 M EDTA, pH 8.0.
3. Recover the resulting RNA products by precipitation with 250 µL of 100% ethanol
at −20°C, centrifuge as described in step 4 of Basic Protocol 1, and resuspend the
pelleted RNA in 40 µL of 2× urea loading buffer.
Preparation of the RNA pool differs in two main ways from the method described previously
(Milligan and Uhlenbeck, 1989). First, an excess (7.5:1 ratio) of GMPS to GTP is used to
favor the incorporation of the thiophosphate-containing nucleotide at the start of most
transcripts. Second, in vitro transcription is conducted under reduced temperature in order
to minimize cleavage (and loss) of functional ribozymes during preparation. The RNase P
ribozyme, like most catalytic nucleic acids, requires Mg2+ to display catalytic function. As
a result, it is important to terminate the transcription reaction with EDTA to preclude
continuing self cleavage of the RNA products.
Gel purify RNA transcription products
4. Separate the transcription products on a 5% denaturing polyacrylamide gel (e.g.,
APPENDIX 3B or CPMB UNIT 7.6).
5. Visualize the RNA precursor band by UV shadowing or autoradiography, and excise
using a sterile razor blade.
6. Recover the isolated RNAs by crush/soaking the gel overnight at 4°C in gel elution
buffer.
7. Precipitate recovered RNAs by the addition of 2.5 vol of 100% ethanol, −20°C, and
pellet by centrifugation as described in step 4 of Basic Protocol 1.
8. Resuspend pelleted RNA in TE buffer, quantitate by liquid scintillation counting, and
store at −20°C.
Perform ribozyme selection and amplification
9. Place 150 µL of Sulfolink gel slurry in a 1.5-mL microcentrifuge tube, add 300 µL
loading buffer, and swirl to wash the beads. Pellet beads by brief centrifugation.
Repeat for total of three washes.
10. Cover the beads with 300 µL loading buffer containing 16 µg Bacillus subtilis rRNA
(or other nonpool RNA) and let stand 45 min at 25°C.
This prebinding serves to occupy nonspecific RNA binding sites on the agarose matrix.
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11. To refold RNAs, preincubate 100 pmol 5′-thiophosphate-terminated RNA molecules
(from step 8) in 300 µL loading buffer for 3 min at 65°C, then for 1 min at 50°C.
12. Combine washed gel beads and preincubated RNA solution, and incubate 1 to 2 hr
at room temperature.
13. Remove unbound RNAs from the matrix with four successive washes each using 300
µL wash buffer as described in step 9, followed by four additional washes each using
300 µL reaction buffer −Mg2+.
14. Resuspend the final washed RNA/bead slurry in 225 µL reaction buffer −Mg2+, giving
a total volume of ∼370 µl. Allow the mixture to equilibrate at 50°C for 1 min. Initiate
reactions by the addition of 9 µL of 1 M MgCl2 (giving a final concentration of ∼25
mM cofactor).
15. After the desired incubation time, terminate reaction by the addition of 30 µL EDTA.
16. Add 5 µg glycogen, then precipitate with ethanol as described in step 4 of Basic
Protocol 1 to recover the ribozymes.
The glycogen aids in precipitating even small amounts of RNA.
17. Resuspend the resulting pellet in 25 µL TE buffer.
18. Use the RNAs as a substrate for RT-PCR using appropriate DNA oligomers (to
convert the RNAs into cDNA and amplify them; see UNIT 9.3 for RT-PCR procedure).
The entire protocol, beginning with in vitro transcription, is repeated in an iterative fashion
until satisfactory catalytic activity is observed with the RNA pool. Molecules present in the
final pool are cloned and sequenced to facilitate further analysis of the resulting ribozyme
variants.
BASIC
PROTOCOL 3
IN VITRO SELECTION OF NEW KINASE RIBOZYMES FROM RANDOM
SEQUENCE
Due to the enormous numbers of oligonucleotides that can be screened simultaneously
by in vitro selection, it is practical to isolate entirely new and complex ribozymes from
random-sequence pools. This was first demonstrated by Bartel and Szostak (1993), who
isolated a series of “ligase” ribozymes from a large pool of random-sequence RNAs.
Lorsch and Szostak (1994) expanded on this approach by creating a biased pool that
carried both random-sequence and preexisting functional RNA domains in their success-
ful search for “kinase” ribozymes (Fig. 9.4.3). The selection protocol for the latter study
is described below.
Materials
2× kinase selection buffer (see recipe)
100 mM adenosine 5′-O-(3-thiotriphosphate) (ATP-γS; Sigma)
100% ethanol, −20°C
Binding buffer: 1 mM EDTA/25 mM HEPES (pH 7.4 at 23°C)
Thiopyridine-activated thiopropyl Sepharose 6B (Amersham Pharmacia Biotech)
Wash buffer: 1 M NaCl/5 mM EDTA/25 mM HEPES (pH 7.4 at 23°C)
Urea solution: 3 M urea/5 mM EDTA
0.1 M 2-mercaptoethanol
3 M sodium acetate, pH 5.2 (APPENDIX 2A)
Chromatographic column
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Figure 9.4.3 Scheme for the isolation of self-phosphorylating ribozymes from a biased RNA pool
that includes random-sequence domains. The pool is composed of three regions of random
nucleotide sequence that are intermixed with a mutagenized (d = 0.15; Breaker and Joyce, 1994a)
ATP-binding domain. Pool RNAs must be dephosphorylated each round to remove the 5′-triphos-
phate moiety that results from preparative in vitro transcription. RNAs that acquire the thiophosphate
moiety of ATP-γS in the selection reaction (inset) are selectively captured by a thiophilic resin. RNAs
bound by the resulting disulfide bond are specifically eluted with 2-mercaptoethanol and are
amplified by RT-PCR. The variable d represents the nucleotide degeneracy at each of the specified
positions in the polynucleotide chain (e.g. d = 0.15 reflects a 0.85 probability of finding the wild-type
nucleotide and a 0.15 probability of finding one of the three remaining nucleotides at a given
position).
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1. Prepare mutagenized RNA pool for kinase ribozyme selection, at 20 pmol/µL.
In the original study reported by Lorsch and Szostak (1994), a mutagenized ATP-bind-
ing domain was integrated with random-sequence domains to create the RNA pool.
Briefly, two synthetic DNAs that correspond to the two halves of the final RNA pool
(Fig. 9.4.3) were made double stranded by PCR, treated with the restriction enzyme
BanI, and joined using T4 DNA ligase. The ligated pool of DNA templates was
transcribed in vitro using T7 RNAP, and the resulting pool of RNA transcripts was
purified by polyacrylamide gel electrophoresis. At this stage, each RNA molecule
carried a 5′-terminal triphosphate moiety that would block autophosphorylation at
this position. Therefore, the RNA pool was treated exhaustively with alkaline phos-
phatase prior to the selection reaction in order to generate RNA precursors each
carrying a hydroxyl group at their 5′ terminus. Alternatively, a pool composed exclu-
sively of random-sequence RNAs can be prepared (see UNIT 9.2).
2. Combine 500 µL of 2× selection buffer, 440 µL distilled water, and 50 µL of 20
pmol/µL pool RNA solution. Allow mixture to equilibrate at 23°C for several
minutes.
3. Initiate the ribozyme reaction by the addition of 10 µL ATP-γS and incubate 20 hr at
23°C.
4. Precipitate the RNA by the addition of 2.5 mL of 100% ethanol, −20°C, followed by
centrifugation as described in step 4 of Basic Protocol 1. Resuspend the pelleted RNA
in 500 µL binding buffer.
5. Combine the RNA solution with an equal volume of a slurry of the activated
thiopropyl Sepharose and incubate 30 min at 23°C.
6. Prepare a column (e.g. 0.8 × 4 cm poly-prep., Bio-Rad) with the RNA/Sepharose
mixture. Remove unbound RNAs from the matrix by washing with 20 bed volumes
each of wash buffer, distilled H2O, and urea solution.
7. Elute disulfide-linked RNAs with 1 column volume 0.1 M 2-mercaptoethanol.
8. Add 3 M sodium acetate, pH 5.2, to the recovered RNA solution to give a final
concentration of 0.3 M. Precipitate the RNA by the addition of 2.5 vol of 100%
ethanol, −20°C, followed by centrifugation as described in step 4 of Basic Protocol
1.
As stated in Basic Protocol 1, during the first few rounds of selection it may be best to
incubate the ribozyme reaction for extended times to allow suboptimal ribozymes greater
opportunity to react. In later rounds, reducing the reaction time will favor those ribozymes
with faster catalytic rates. Other reaction conditions, such as concentrations of ATP-γS
or divalent metal ions, can be adjusted to favor ribozymes that have greater affinities for
these agents.
BASIC
PROTOCOL 4
CONTINUOUS EVOLUTION OF LIGASE RIBOZYMES
A new method for the continuous evolution of ribozymes has proven to be a powerful
means to isolate ligase ribozyme variants with modified catalytic activity. Continuous
evolution is a dynamic process whereby ribozymes that best serve as catalysts and as
templates for cDNA synthesis and RNA transcription dominate the population of ampli-
fying RNAs. Therefore, any variations in the catalysis and amplification cycle can be
made so long as the protein enzymes that facilitate RNA and DNA synthesis are not
rendered inactive. Outlined below is a protocol used by Wright and Joyce (1997) to
propagate variants of RNA ligase ribozymes.
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Materials
10× reaction buffer (see recipe)
10× 3SR NTP/dNTP mix: 20 mM each of the four ribonucleoside-5′-triphosphates
and 2 mM each of the four deoxyribonucleoside-5′-triphosphates (see APPENDIX
2A for NTP and dNTP preparation details)
DNA primer 1: complementary to the 3′ tail of the pool RNAs (20 pmol/µL)
Substrate oligonucleotide: DNA/RNA chimera that encodes the T7 promoter
sequence (20 pmol/µL)
40 U/µL T7 RNAP (New England Biolabs)
200 U/µL Moloney murine leukemia virus reverse transcriptase (MMLV RT;
Amersham)
1. Prepare mutagenized RNA pool for continuous evolution.
Initial pools for the first round of continuous evolution can be prepared by in vitro
transcription from synthetic DNAs (mutagenized during chemical synthesis) or from DNA
templates that resulted from RT-PCR amplification of the selected ribozymes (see UNIT 9.3).
A primary concern when initiating the continuous evolution experiment is the catalytic
speed of the starting ribozyme. The prototype ribozyme used by Wright and Joyce (1997)
to generate the starting RNA pool for their RNA ligase selection experiment was an
inefficient catalyst that could not compete successfully with selfish RNAs. As a result, the
authors subjected a pool of 1014 ribozyme variants to several conventional rounds of in
vitro selection followed by an intermediate form of continuous evolution to enrich the RNA
population with highly active ribozymes. This more efficient population of ribozymes
subsequently was used to initiate the continuous evolution process. Similarly, individual
ribozymes that meet this activity threshold must be present in the starting RNA population
in order to initiate the continuous evolution process.
2. Combine in a 1.5-mL microcentrifuge tube (20 µL total volume):
5.5 µL distilled H2O
1 µL pool RNA
2 µL 10× reaction buffer
2 µL 10× 3SR NTP/dNTP mix
2.5 µL 20 pmol/µL DNA primer 1
5 µL 20 pmol/µL substrate oligonucleotide
1 µL 40 U/µL T7 RNAP
1 µL 200 U/µL MMLV RT.
Incubate 1 hr at 37°C.
3. Dilute an aliquot of the reaction mixture 50-fold with distilled H2O. Either proceed
with the next serial transfer or store the diluted sample at −20°C for future use.
Iterations involving serial dilution of the pool followed by repetition of the reaction can be
carried out indefinitely. This continuous evolution format favors catalytic RNAs that
perform the ligation reaction most rapidly. As the selective-amplification cycles proceed
and the ribozymes become more efficient, stages of the cycle other than the catalytic step
may become limiting to the overall process. Propagation of ribozyme variants that
overcome whatever is the rate-limiting (catalytic or amplification) step will dominate the
population of amplifying RNAs. This feature of continuous evolution could be exploited to
examine the mechanisms and kinetics of nucleic acid amplification in addition to catalysis.
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REAGENTS AND SOLUTIONS
Use distilled, deionized water or other ultrapure water in all recipes and protocol steps. For common
stock solutions, see APPENDIX 2A; for suppliers, see SUPPLIERS APPENDIX.
Gel elution buffer
0.3 M sodium acetate
10 mM Tris⋅Cl, pH 7.4 (APPENDIX 2A)
1 mM EDTA (APPENDIX 2A)
0.5% (w/w) sodium dodecyl sulfate (SDS; APPENDIX 2A)
Autoclave and store indefinitely at room temperature
Reaction buffer for continuous evolution, 10× 
500 mM EPPS [4-(2-hydroxethyl)-1-piperazinepropanesulfonic acid],
pH 8.5 at 23°C
500 mM KCl
250 mM MgCl2
40 mM dithiothreitol (DTT)
20 mM spermidine
Store indefinitely at –20°C
Reaction buffer −Mg2+ (for ribozyme selection)
3 M sodium acetate
44.5 mM Tris⋅Cl (APPENDIX 2A)
16 mM piperazine-N,N’-bis(2-hydroxypropanesulfonic acid) (PIPES)
0.05% SDS (APPENDIX 2A)
Adjust pH to 8 with NaOH
Store indefinitely at –20°C
Selection buffer, 2×
50 mM HEPES (N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid),
pH 7.4 at 23°C
100 mM MgCl2
10 mM MnCl2
800 mM KCl
Store indefinitely at –20°C
Transcription buffer for in vitro selection, 10×
400 mM Tris⋅Cl (APPENDIX 2A), pH 8.1 at 37°C
60 mM MgCl2
50 mM DTT
10 mM spermidine
0.1 % (v/v) Triton X-100
50 µg/mL bovine serum albumin (BSA)
Store indefinitely at –20°C
COMMENTARY
Background Information
Catalytic nucleic acids and in vitro selection
An essential characteristic of any class of
polymers that is capable of supporting diverse
catalytic activity is the ability to form a nearly
endless array of higher-ordered folding pat-
terns. This structural sophistication allows the
polymer to form precise active sites for specific
binding of substrates and for catalysis of chemi-
cal transformations. Beginning with the deter-
mination of the three-dimensional structure of
tRNAPhe (Kim et al., 1973; Robertus et al.,
1974), it has become increasingly clear over the
last two decades that RNA has enormous po-
tential for forming unique secondary and terti-
ary structures (Gold et al., 1995; Osborne and
Ellington, 1997). Evidence that this structural
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complexity could be exploited to form catalytic
RNAs was first obtained upon the discovery of
natural ribozymes that self splice (Kruger et al.,
1982) and that function as RNA endonucleases
(Guerrier-Takada et al., 1983). The collection
of natural and artificial ribozymes has ex-
panded rapidly in recent years to include a wide
range of catalytic activities (Breaker, 1997a;
Jaeger, 1997), providing strong support for the
view that the structure-forming potential of
RNA is more than adequate to allow the forma-
tion of a great diversity of ribozymes that carry
precisely formed active sites.
The many examples of catalytic RNAs also
provide compelling evidence for the notion that
an “RNA world” may have preceded the pro-
tein-dominated metabolic processes that are in
operation today (White, 1976; Gilbert, 1986;
Cech, 1993; Benner et al., 1989). Although
always a topic of debate, this theory has in-
spired many who study nucleic acids to aggres-
sively seek new ribozymes that catalyze reac-
tions believed to be central to the origin and
evolutionary progression of life. In addition,
researchers continue to probe the limits of bio-
catalysts both under cellular conditions and
when the biochemical rules and reaction con-
ditions are no longer set by living organisms.
Even DNA can be forced to function as an
enzyme outside the confines of living cells
(Breaker, 1997b), suggesting that the perceived
biological limitations for catalytic nucleic acids
may be overcome simply by using the latest
strategies for the design of novel nucleic acids.
Almost without exception, the search for
new ribozymes and deoxyribozymes makes use
of in vitro selection methods, which have
proven to be the most effective approach for
producing new or altered RNA catalysts
(Breaker, 1997a). In vitro selection relies on the
probability that only one or perhaps a few
individuals amongst trillions of random-se-
quence molecules can promote the chemical
reaction of interest. This process makes use of
selection and amplification procedures that are
performed repetitively to recover these rare
catalysts from the pool of inactive molecules.
Critical to the success of an in vitro selection
experiment is the judicious design of the selec-
tion and amplification protocol. As with natural
selection, these “test-tube evolution” experi-
ments are unforgiving and can give rise to
spurious products unless great care and fore-
thought are given to the design of the experi-
mental methodology (see UNIT 9.3 for further
discussion on “molecular parasites”). Unfortu-
nately, methods for the selection of catalytic
RNAs and DNAs must be revised for each new
catalytic activity sought, each time forcing the
careful reevaluation of the protocols to be em-
ployed.
Given the expected functional diversity of
RNA and DNA, a wide range of chemical and
molecular biological techniques will be needed
to successfully and efficiently expand the cata-
lytic repertoire of nucleic acids. The protocols
described herein are representative of the many
existing methods that have been used success-
fully to isolate ribozymes with new or improved
catalytic function. Future efforts in this field no
doubt will expand the catalytic repertoire of
RNA and DNA, probe the limits of function
with existing catalysts, and create superior
RNA and DNA catalysts that have utility be-
yond basic science. Whether the experimenter’s
specific goal is to identify new classes of cata-
lytic nucleic acids, or to focus the selection
pressure precisely on a individual kinetic pa-
rameter of an existing enzyme, new or modified
selection strategies and methods most likely
will need to be devised.
Early selection experiments with group I
ribozymes
One of the first ribozymes to be subjected to
in vitro selection is the group I self-splicing
ribozyme. This ribozyme forms an intron of the
26S ribosomal RNA precursor from the ciliated
protozoan Tetrahymena thermophila, which is
known to self process (Kruger et al., 1982). The
Tetrahymena ribozyme has been used as a start-
ing point for a number of pioneering in vitro
selection experiments that tested the methods,
possible strategies, and the limitations of dif-
ferent selective-amplification processes. Al-
though this ribozyme normally promotes two
successive RNA phosphoester transfer reac-
tions that produce spliced exons, reorganized
forms of the enzyme have been made to cata-
lyze several related reactions including RNA
cleavage, oligonucleotide polymerization/de-
polymerization, and dephosphorylation reac-
tions (Cech, 1990). More recently, in vitro se-
lection has been used to isolate variants of
group I ribozymes that have new functions such
as DNA cleavage (Beaudry and Joyce, 1992;
Tsang and Joyce, 1996) and altered metal-ion
dependence (Lehman and Joyce, 1993), or that
have new or altered structural domains (e.g.,
Green et al., 1990; Williams et al., 1994; Costa
and Michel, 1997). Similar investigations are
now being conducted with other large ri-
bozymes.
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Continuous evolution of ribozymes
Most in vitro selection experiments proceed
in a punctuated fashion, meaning that the ex-
perimenter must actively participate in the se-
lection process through manual intervention or
automated processing. For example, the selec-
tion and amplification steps of most simulated
evolutionary processes each require time-con-
suming manipulations such as gel purification,
column chromatography, gel elution, nucleic
acid precipitation, or separate enzyme reactions
for the amplification of selected products.
Without this intervention the selection process
would cease and only a portion of a given round
of selection would be completed. Depending
on the complexity of the selection process, this
demand for manipulation adds days or weeks
to the time that the catalytic molecules actually
are performing as catalysts, and these manipu-
lations can become annoyingly repetitive.
For one class of reactions at least, this proc-
ess has been simplified by employing a selec-
tive-amplification method that almost com-
pletely eliminates the need for experimenter
intervention. “Continuous evolution” of cata-
lytic RNA function has been demonstrated
(Wright and Joyce, 1997) using a variant of the
ligase ribozymes isolated by Bartel and Szostak
(1993). This scheme (Fig. 9.4.4) was designed
to couple the catalysis and amplification proc-
esses in order to create a self-sustaining system
whereby the fastest ribozymes become avail-
able for selective amplification sooner than
their molecular competitors (Breaker and
Joyce, 1994b). The resulting amplification
process creates molecular progeny molecules
that again need to promote the ligation reaction
in order to replicate. Infinite cycles of coupled
selection and amplification can proceed in a
continuous fashion using a serial transfer pro-
cedure, whereby a portion of the preceding
reaction is used to initiate a fresh reaction
mixture. Coupled catalysis and amplification
processes, however, are prone to the generation
of selfish nucleic acids that replicate without
the need for catalysis (Breaker and Joyce, 1994;
Breaker et al., 1994). Therefore great care must
be taken to prevent these molecules from over-
taking the RNA population.
Critical Parameters
There are an almost overwhelming number
of issues that must be considered when initiat-
ing an in vitro selection project. Unfortunately,
how many of these critical parameters should
be addressed will change depending on the
goals of the project. Of foremost importance is
the catalytic activity sought by the researcher.
For example, one may want to have some con-
fidence that molecules within the pool can
catalyze the target reaction before committing
time and resources to an in vitro selection effort.
In many cases, in vitro selection is limited to
isolating catalysts with a rate constant of at least
10−5 min−1—which equates to a half life for the
precursor of ∼5 days for self-modifying en-
zymes. To effectively isolate enzymes with
poorer rate constants, even longer incubation
times for the selection would be necessary to
allow a significant number of enzymes to react.
In addition, most catalysts isolated from ran-
dom-sequence pools catalyze the target reac-
tion with rates that are <1-million-fold above
the equivalent uncatalyzed reaction, although
in many instances additional rounds of muta-
tion and selection do result in greater rate en-
Figure 9.4.4 Scheme for the continuous in
vitro evolution of ligase ribozymes. A mu-
tagenized population of self-ligating ribozymes
is incubated in the presence of reverse tran-
scriptase (RT), RNA polymerase (RNAP), and
oligonucleotide substrate. Functional ri-
bozymes in this mixture undergo a sequence of
ribozyme- and protein enzyme–mediated reac-
tions in order to replicate. RNAs that catalyze
the formation of a new 3′-5′ linkage to a sub-
strate oligonucleotide (at the expense of the
5′-terminal triphosphate moiety) acquire a pro-
moter sequence that is specific for the constitu-
ent RNA polymerase. Upon reverse
transcription, the chimeric RNA-DNA hybrids
formed from active ribozymes now carry a dou-
ble-stranded promoter element. RNA polym-
erase ini t iates transcr ipt ion form this
double-stranded sequence, producing new
RNA enzymes each with a regenerated 5′-
triphosphate terminus. These new RNAs, some
of which carry new mutations as a result of the
inherent infidelity of the polymerizing enzymes,
can participate in the next round of selective
amplification.
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hancements. Therefore, targeting a reaction
that has a rate constant for the uncatalyzed
reaction of 10−11 or lower is expected to be very
challenging.
In general, maximizing both the pool diver-
sity and the size of the mutagenized domains
will increase the probability that the catalysts
of interest will be represented. However, these
parameters must be balanced with practical
considerations such as the ease and expense of
pool construction and the technical challenges
posed by the amplification and manipulation of
larger oligonucleotide constructs. The intro-
duction of mutations into preexisting ri-
bozymes is also of great importance. Too small
a number of mutations will not allow sampling
of ribozyme variants that have the catalytic
parameters of interest, while too large a number
of mutations may create variant that are so
distant from the original ribozyme that entirely
new catalytic motifs with the same catalytic
function will be isolated.
Extreme care must be exercised during all
stages of the selection protocol, as most tech-
nical problems can result in a reduction of the
sequence diversity comprising the pool. This is
particularly important during the early stages
of any selection project. In many cases, a cata-
lytic “signal” from the population that could be
used to confirm satisfactory progress may not
appear until several rounds of selection have
been completed. Since many in vitro selection
protocols are assembled using routine molecu-
lar biology techniques, precautions used to en-
sure success with these techniques should be
exercised faithfully throughout the entire selec-
tion process.
Anticipated Results
If successful, a typical in vitro selection
protocol yields a population of functional
molecules within three to ten rounds of selec-
tive amplification. The exact performance of
each selection experiment will depend upon a
number of factors, such as the frequency of
active molecules in the original pool and the
stringency of the selection process. However,
it must be noted that ∼50% of all reported
ribozyme-selection experiments to date have
yielded molecules that survive the selection
protocol by some mechanism other than that
originally intended by the investigators. These
unexpected “answers” range from simple “mo-
lecular parasites” that do not perform chemical
reactions, to catalysts that promote reactions
that are distinct from the desired reaction. If
these undesirable molecules emerge during in
vitro selection, each must be assessed and dealt
with on an individual basis given the innumer-
able possible mechanisms by which they may
survive.
Time Considerations
The time required to successfully complete
an in vitro selection experiment will vary
widely depending on the complexity of the
selection protocol and on the challenge of the
reaction that is presented to the pool of mole-
cules. Most of the standard molecular biology
techniques typically used when assembling se-
lection protocols can be completed within sev-
eral hours. However, more complicated in vitro
selection protocols may be comprised of a
dozen or more techniques for each round that
together may require several days to complete.
For most in vitro selection efforts, the re-
searcher should be prepared to devote several
months to the selection phase of the study.
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